Prognostic value of the International Scoring System and response in patients with advanced Waldenstrom macroglobulinemia

Haematologica. 2011 May;96(5):785-8. doi: 10.3324/haematol.2010.029140. Epub 2011 Mar 10.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Disease Progression
  • Disease-Free Survival
  • Female
  • Humans
  • International Classification of Diseases*
  • Male
  • Middle Aged
  • Prognosis
  • Recurrence
  • Rituximab
  • Time Factors
  • Treatment Outcome
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives
  • Waldenstrom Macroglobulinemia / drug therapy*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab
  • Cyclophosphamide
  • Vidarabine
  • fludarabine